T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

T2 Biosystems (NASDAQ:TTOO) announced its participation in the H.C. Wainwright Global Investment Conference scheduled for September 13, 2022, at 3:00 PM ET. The company specializes in rapid detection of sepsis-causing pathogens and antibiotic resistance. Attendees can access a live and recorded webcast of the presentation from the company’s website. T2 Biosystems aims to enhance patient care with products powered by its proprietary T2 Magnetic Resonance technology, including the T2Dx® Instrument and various diagnostic panels for pathogens and antimicrobial resistance.

LEXINGTON, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright Global Investment Conference in New York, New York.

Management is scheduled to present on Tuesday, September 13, 2022, at 3:00pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com.

About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Biothreat™ Panel, the T2Cauris™ Panel, and T2Lyme™ Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.

Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406

FAQ

When is T2 Biosystems presenting at the H.C. Wainwright Global Investment Conference?

T2 Biosystems will present on September 13, 2022, at 3:00 PM ET.

Where can I watch T2 Biosystems' presentation from the conference?

The presentation can be accessed via a live and recorded webcast on T2 Biosystems' website.

What does T2 Biosystems focus on?

T2 Biosystems focuses on rapid detection of sepsis-causing pathogens and antibiotic resistance genes.

What products does T2 Biosystems offer?

T2 Biosystems offers products like the T2Dx® Instrument and diagnostic panels for bacterial, fungal pathogens, and antimicrobial resistance.

What is T2 Biosystems' stock symbol?

The stock symbol for T2 Biosystems is TTOO.